
Manchester Science Partnerships (MSP) and its joint venture partner Manchester University NHS Foundation Trust (MFT) have secured planning permission for the £35m fourth phase expansion of the Citylabs health innovation campus in the UK.
The 125,000ft2 expansion, known as Citylabs 4.0, is planned to be built at the south of the MFT Oxford Road campus, adjacent to Citylabs 2.0 & 3.0. The latest expansion will provide seven floors of office and lab space.
The first phase expansion, Citylabs 1.0, is already home to several diagnostics, medtech, digital health and genomics businesses while construction is underway on the £25m second phase, Citylabs 2.0.
Scheduled for completion in summer 2020, the Citylabs 2.0 campus will serve as European Hub for Diagnostics Development for global diagnostics company QIAGEN.
Construction is planned to begin on Citylabs 3.0, which is the redevelopment of the Old Saint Mary’s Hospital and adjoining chapel, following the completion of Citylabs 2.0.
NHS said that the Citylabs 4.0 development marks a step ahead for Manchester’s Oxford Road Corridor innovation district, which is claimed to be Europe’s largest clinical academic campus.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataSheppard Robson designed the Citylabs 4.0 development alongside Arup and Hilson Moran. Deloitte is serving as planning consultancy while cost consultancy services are provided by Gardiner and Theobald.
MSP managing and Bruntwood SciTech – Manchester director Tom Renn said: “Manchester’s life science sector continues to thrive and continues to make a statement in being the place to be for start-ups, scale ups and international companies in the sector to cluster together.
“We can facilitate direct collaboration with the NHS and the ability for companies to accelerate getting their product or service into the healthcare market faster, something truly unique to our city.”
———————————————————————————————————————-
Illustration of Citylabs 4.0 development in the UK. (Credit: CMFT)